Reducing Drug Prices for Seniors Act.

# Reducing Drug Prices for Seniors Act (S 2617) - Plain Language Summary **What the Bill Would Do:** This bill would change how Medicare calculates what seniors pay for prescription drugs. Currently, seniors' out-of-pocket costs are based on the full "list price" of medications. Under this bill, those costs would instead be based on the lower "net price"—the actual price after drug manufacturers offer discounts or rebates.

In practical terms, if a drug's list price is $100 but a manufacturer discount brings it down to $70, seniors would pay their coinsurance (percentage cost-sharing) based on the $70 price rather than the $100 price. **Who It Affects:** Primarily Medicare beneficiaries (seniors age 65 and older) who take prescription drugs covered under Medicare's Part D benefit program. The bill could potentially affect drug manufacturers as well, since their discounts would directly reduce what patients pay. **Current Status:** The bill was introduced by Senator Jacky Rosen (D-Nevada) in the 119th Congress and is currently in committee, meaning it has not yet been voted on by the full Senate. No further action has been taken at this time.